UPDATE: Jazz Pharma Settlement Dictates Amneal Will Have Non-Exclusive Rights To Sell Limited Volume Of An Authorized Generic Version Of Xyrem From Jul. 1, 2023 To Dec. 31, 2025 Or Earlier Under Certain Circumstances